文献速递急性肾损伤

急性肾损伤、系统性炎症与长期认知功能:ASSESS-AKI研究

Acute Kidney Injury, Systemic Inflammation, and Long-Term Cognitive Function: ASSESS-AKI.
PubMed 文献 · Clin J Am Soc Nephrol · 2024-05-10

ASSESS-AKI研究纳入1538例住院后存活3个月的患者,按人口学、合并症和基线肾功能匹配有无AKI。AKI患者3年时3MS评分较低(差值-1.1,95%CI -2.0至-0.3,P=0.009),且3个月时血浆可溶性TNF受体1介导了35%(P=0.02)的AKI相关认知下降风险。

要点

  • AKI与3年时认知功能下降相关,3MS评分差值-1.1。
  • AKI患者3年时≥5分认知下降比例更高(14% vs 10%,P=0.04)。
  • 可溶性TNF受体1介导35%的AKI相关长期认知损害风险。

核心结论

  • AKI与较低的3MS评分相关,可溶性TNF受体1似乎介导了长期认知损害风险的显著部分。
  • 需进一步研究确定AKI是认知损害的病因还是标志物。

研究设计与样本

  • ASSESS-AKI队列纳入住院后存活3个月、按人口学、合并症和基线肾功能匹配的有无AKI患者。
  • 1538例参与者中1420例(92%)完成3个月3MS评估并有匹配对象。
  • 部分子集在3、12、36个月接受改良简易智力状态检查(3MS)认知测试。

主要发现

  • AKI患者3年时3MS评分较无AKI者低(差值-1.1,95%CI -2.0至-0.3,P=0.009)。
  • AKI患者3年时3MS评分≥5分临床意义下降的比例更高(14% vs 10%,P=0.04)。
  • 3个月时血浆可溶性TNF受体1介导35%(P=0.02)的AKI相关3年3MS评分风险。

临床怎么用

  • 对AKI存活者应关注长期认知功能下降风险。
  • 可溶性TNF受体1或可作为AKI后认知损害风险分层的炎症标志物。

局限性

  • 研究为观察性设计,无法确定AKI与认知损害的因果关系。
  • 仅部分子集完成认知测试,可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

KEY POINTS: This study highlights that AKI is associated with long-term cognitive decline. Soluble TNF receptor 1 concentrations seem to mediate a significant proportion of the risk of long-term cognitive impairment after AKI. BACKGROUND: Cognitive dysfunction is a well-known complication of CKD, but it is less known whether cognitive decline occurs in survivors after AKI. We hypothesized that an episode of AKI is associated with poorer cognitive function, mediated, at least in part, by persistent systemic inflammation. METHODS: Assessment, Serial Evaluation and Subsequent Sequelae of AKI enrolled patients surviving 3 months after hospitalization with and without AKI matched on the basis of demographics, comorbidities, and baseline kidney function. A subset underwent cognitive testing using the modified mini-mental status examination (3MS) at 3, 12, and 36 months. We examined the association of AKI with 3MS scores using mixed linear models and assessed the proportion of risk mediated by systemic inflammatory biomarkers. RESULTS: Among 1538 participants in Assessment, Serial Evaluation and Subsequent Sequelae of AKI, 1420 (92%) completed the 3MS assessment at 3 months and had a corresponding matched participant. Participants with AKI had lower 3MS scores at 3 years (difference −1.1 [95% confidence interval, −2.0 to −0.3] P = 0.009) compared with participants without AKI. A higher proportion of participants with AKI had a clinically meaningful (≥5 point) reduction in 3MS scores at 3 years compared with participants without AKI (14% versus 10%, P = 0.04). In mediation analyses, plasma-soluble TNF receptor-1 at 3 months after AKI mediated 35% (P = 0.02) of the AKI-related risk for 3MS scores at 3 years. CONCLUSIONS: AKI was associated with lower 3MS scores, and Soluble TNF receptor 1 concentrations seemed to mediate a significant proportion of the risk of long-term cognitive impairment. Further work is needed to determine whether AKI is causal or a marker for cognitive impairment.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Bhatraju PK, Zelnick LR, Stanaway IB, et al. Acute Kidney Injury, Systemic Inflammation, and Long-Term Cognitive Function: ASSESS-AKI. Clin J Am Soc Nephrol. 2024. PMID: 38728094. doi:10.2215/CJN.0000000000000473

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。